Multifaceted Casr

  • Increase font size
  • Default font size
  • Decrease font size
Home Item-wolfgang Aspects of Multifaceted CaSR

Aspects of Multifaceted CaSR


The Network is designed around two counterbalancing imperatives: the need for sufficient size to provide the required range of expertise needed, and the need to be sufficiently small to provide flexibility without bureaucracy. This has been achieved with ten partners – seven from academia and three from industry. The Academic Partners are laboratories at the forefront of biomedical research, working on, amongst other topics, several aspects of cancer and cardiovascular disease. The Industrial Partner, AstraZeneca, has major interest in development of drugs and signalling through the CaSR.

Amgen ltd., one of the associate partners, produces Cinacalcet, first and only allosteric modulator of a GPCR available on the market, therefore it is profoundly interested in any novel clinical applications for modulators of the CaSR. Together the partners provide a mass of expertise across the range of skills required for Translational Science. The Associated Partners involved in training are instrumental in providing practical training topics or methodologies. All participants in the Nework (PIs and ESRs) will profit from the experience of online cooperation provided by FHJ. AHT-Management Kft. will bring the specialist expertise of a Management Consultancy well versed in Management Systems.


Multifaceted CaSR is a Marie Curie Action
funded by the European Commission
under the 7th Framework Programme

Official Sponsors of the 1st CaSR Symposium

Sponsors of the first CaSR Symposium





Flyer 3rd Symposium on CaSR